IP Library Granted Patent US 10,017,796
Granted Patent B2
US 10,017,796 · App. 14/432,579 · Granted Jul 10, 2018

Transgenic microalgae with increased production of at least one omega-3 long chain polyunsaturated fatty acid

Inventors: Jonathan A. Napier (Harpenden, GB); Olga Sayanova (Harpenden, GB); Mary Hamilton (Harpenden, GB); Royah Vaezi (Harpenden, GB)
Assignee: ROTHAMSTED RESEARCH LIMITED
C12P7/6427A23L33/12A61K36/02C11B1/00C12N1/12C12N9/0071C12N9/1025C12N9/93C12N15/79C12N15/8247C12P7/6472C12Y114/19003C12Y602/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,017,796
App. No.
14/432,579
Granted
Jul 10, 2018
Kind
B2
Abstract

The invention relates to genetically modified organisms with enhanced production of omega-3 long chain polyunsaturated fatty acids.

Claims (20)

1. A transgenic microalgae with increased production of at least one omega-3 long chain polyunsaturated fatty acid (LC-PUFA) compared to a control microalgae,

wherein the transgenic microalgae overexpresses a nucleic acid encoding a Δ5-elongase and/or Δ6-desaturase, wherein the nucleic acid encoding the Δ5-elongase is selected from SEQ ID NO:1 and a sequence that encodes a Δ5-elongase that has at least 75% homology to SEQ ID NO:2, and wherein the nucleic acid encoding a Δ6-desaturase is selected from SEQ ID NO:3; a sequence that encodes a Δ6-desaturase that has at least 75% homology to SEQ ID NO:4; SEQ ID NO:5; SEQ ID NO:7; a sequence that encodes a Δ6-desaturase that has at least 75% homology to SEQ ID NO:8; SEQ NO:9 and a sequence that encodes a Δ6-desaturase that has at least 75% homology to SEQ ID NO:10;

wherein the omega-3 LC-PUFA is EPA and/or DHA, and wherein, when the omega-3 LC-PUFA is EPA, the increase is to at least 20% of the total fatty acid content, and when the omega-3 LC-PUFA is DHA, the increase is to at least 7% of the total fatty acid content; and

wherein the transgenic microalgae is selected from Phaeodactylum, Nannochloropsis, Thraustochytrium, Schizochytrium , or Thalassiosira.

2. A transgenic microalgae of claim 1 , wherein the nucleic acid further comprises a regulatory sequence.

3. A method for producing transgenic microalgae with an increased omega-3 LC-PUFA content compared to a control microalgae, the method comprising transforming a microalgae with a nucleic acid encoding a Δ5-elongase in order to increase the content of DHA or a nucleic acid encoding Δ6-desaturase in order to increase the content of EPA, wherein said nucleic acid encoding a Δ5-elongase is selected from SEQ ID NO:1 and a sequence that encodes a Δ5-elongase that has at least 75% homology to SEQ ID NO:2, and wherein the nucleic acid encoding a Δ6-desaturase is selected from SEQ NO:3; a sequence that encodes a Δ6-desaturase that has at least 75% homology to SEQ ID NO:4; SEQ ID NO:5; SEQ ID NO:7; a sequence that encodes a Δ6-desaturase that has at least 75% homology to SEQ ID NO:8; SEQ ID NO:9 and a sequence that encodes a Δ6-desaturase that has at least 75% homology to SEQ ID NO:10.

4. A method for increasing production of one or more omega-3 LC-PUFAs in microalgae, the method comprising

a) cultivating a transgenic microalgae of claim 1 under conditions which allow for the production of one or more omega-3 LC-PUFAs and

b) obtaining the one or more omega-3 LC-PUFAs from the transgenic microalgae.

5. A method of claim 4 , wherein the omega-3 LC-PUFA is DHA.

6. A method of claim 4 , wherein the omega-3 LC-PUFA is EPA.

7. A composition comprising a transgenic microalgae of claim 1 .

8. A method for making a feedstuff, the method comprising

a) cultivating a transgenic microalgae of claim 1 under conditions allow for the production of one or more omega-3 LC-PUFAs;

b) obtaining one or more omega-3 LC-PUFAs from the transgenic microalgae; and

c) making a feedstuff from the one or more omega-3 LC-PUFAs.

9. The transgenic microalgae of claim 1 , wherein the control microalgae has not been genetically modified to alter the content of omega-3 LC-PUFAs therein.

10. The transgenic microalgae of claim 1 , wherein the transgenic microalgae is Phaeodactylum.

11. The transgenic microalgae of claim 1 , wherein the omega-3 LC-PUFA is DHA and wherein the increase to at least 10% of the total fatty acid content is in the stationary phase.

12. The transgenic microalgae of claim 1 , wherein the omega-3 LC-PUFA is EPA and wherein the increase to at least 20% of the total fatty acid content is in the stationary phase.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2018
From: NAPIER, JOHNATHAN; SAYANOVA, OLGA; VAEZI, ROYAH; HAMILTON, MARY
To: ROTHAMSTED RESEARCH LIMITED
Reel/Frame 046295/0647 →
Priority Claims (1)
GB 1217524.6 · Oct 1, 2012 · national
Continuity (1)
Related Publication 20150275243A1 · Oct 1, 2015